Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$35,547,509
+$10,326,496 QoQ
Shares Held
29,637
+8.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#644
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Advisors, LLC holds $319,084,682 across 12 Drug Manufacturers - General names. LLY ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
414,618 | $105,300,533 | |
| 2 | ABBV |
AbbVie Inc.
|
334,747 | $84,235,735 | |
| 3 | MRK |
Merck & Co., Inc.
|
376,564 | $48,388,474 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
29,637 | $35,547,509 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
93,913 | $11,864,968 | |
| 6 | AMGN |
Amgen Inc
|
31,607 | $11,445,526 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
194,661 | $11,216,366 | |
| 8 | PFE |
Pfizer Inc
|
398,271 | $9,590,365 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,547,509 | 29,637 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $25,221,013 | 27,421 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $29,480,624 | 27,432 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $21,165,620 | 27,740 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $21,720,044 | 27,863 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $22,791,812 | 27,596 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $20,473,440 | 26,520 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $22,350,494 | 25,228 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $23,196,740 | 25,621 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $20,268,969 | 26,054 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $15,315,640 | 26,274 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $14,098,051 | 26,247 | Shares | Sole | 2023-10-16 | |
| 2023-03-31 | $9,460,190 | 27,547 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $10,451,317 | 28,568 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $9,525,891 | 29,460 | Shares | Sole | 2022-10-05 | |
| 2022-06-30 | $9,665,944 | 29,812 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $8,596,827 | 30,020 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $8,228,593 | 29,790 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $6,852,711 | 29,659 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $6,909,470 | 30,104 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $5,440,385 | 29,121 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $5,059,628 | 29,967 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $4,517,274 | 30,518 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $5,019,310 | 30,572 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $4,285,060 | 30,890 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||